FLT3/HDAC-IN-2
CAT:
804-HY-162906
Size:
Inquire
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No
FLT3/HDAC-IN-2
- UNSPSC Description: FLT3/HDAC-IN-2 is (compound 25h) a FLT3/HDAC dual inhibitor. FLT3/HDAC-IN-2 has antiproliferative activity against MOLM-13 cells. FLT3/HDAC-IN-2 can be used in acute myeloid leukemia research[1].
- Target Antigen: FLT3; HDAC
- Type: Reference compound
- Related Pathways: Cell Cycle/DNA Damage;Epigenetics;Protein Tyrosine Kinase/RTK
- Field of Research: Cancer
- Assay Protocol: https://www.medchemexpress.com/flt3-hdac-in-2.html
- Smiles: NC(C1=C(NC2=CC=C(N3CCN(CCCCCCCC(NO)=O)CC3)C(OC)=C2)N=C(NC4CCOCC4)C(CC)=N1)=O
- Molecular Weight: 612.76
- References & Citations: [1]Chang Y, et al. Simultaneous inhibition of FLT3 and HDAC by novel 6-ethylpyrazine-2-Carboxamide derivatives provides therapeutic advantages in acute myelocytic leukemia. Eur J Med Chem. 2024 Sep 6;279:116847.
- Shipping Conditions: Room temperature
- Clinical Information: No Development Reported